1.The Importance of Early Recognition of Cerebral Venous Sinus Thrombosis: A Case Report
Kian Guan Goh ; Viswanathan Shanthi
Malaysian Journal of Medical Sciences 2015;22(5):98-102
A 33-year-old lady presented to the emergency department (ED) of Kuala Lumpur Hospital
with subacute onset of headaches, irritability, and vomiting. Neurological examination revealed a
restless agitated patient, poor responses to verbal commands with a Glasgow Coma Scale of 14/15,
photophobia, blurred nasal margins with generalised weakness, hyperreflexia, and downgoing
plantars. Computed tomography (CT) of the brain showed evidence of biparietal infarction with
an empty delta sign. Urgent magnetic resonance imaging and venography (MRI/MRV) of the brain
in the ED showed evidence of thrombosis of the superior sagittal sinus extending to the torcular
herophili, straight sinus, transverse sinuses, sigmoid sinuses, and proximal internal jugular veins.
The precipitating factor for the thrombosis was possibly oral contraceptive pill usage, which she had
been taking for a month. She was treated aggressively with anticoagulation. The patient subsequently
improved symptomatically and achieved full neurological recovery. In this patient, early recognition
of the clinical symptoms and a CT scan with confirmation by MRI/MRV of the brain enabled the
prompt diagnosis and treatment of cerebral venous sinus thrombosis with a good clinical outcome.
2.Diabetes Insipidus Induced by Combination of Short-acting Octreotide and Lanreotide for Recurrent Carcinoid Crisis of Neuroendocrine Tumour: A case report
Goh Kian Guan ; Subashini Rajoo ; Noraini Mohd Dusa ; Nik Hasimah Nik Yahya ; Mohamed Badrulnizam Long Bidin
Journal of the ASEAN Federation of Endocrine Societies 2021;36(2):220-222
Somatostatin analogue is useful in carcinoid crisis for symptom control. Optimal dosing of somatostatin analogues for carcinoid symptoms is not known. This case highlighted management issues using combination short-acting octreotide infusion with long-acting lanreotide during carcinoid crisis. The patient had left lung neuroendocrine tumour that metastasized to his liver and bone, post left lobectomy. Due to extensive metastasis to the liver causing recurrent carcinoid crisis, he required shorter interval long-acting lanreotide with continuous infusion of short-acting octreotide, which led to transient diabetes insipidus. Symptoms resolved with discontinuation of treatment. Somatostatin analogues, especially in combination, may inhibit the posterior pituitary resulting in diabetes insipidus. Prompt withdrawal of short-acting somatostatin analogue and initiation of desmopressin can reverse the complication. It is important to recognize this complication with combination of octreotide and lanreotide injections to avoid serious complications.
Diabetes Insipidus
;
Octreotide
;
Neuroendocrine Tumors
;
Malignant Carcinoid Syndrome